[ad_1] During the bull market of 2023, the “Magnificent Seven” stocks have dominated financial media…
Tag:
Research/Development
-
-
[ad_1] Moderna Inc.’s stock soared 14% early Thursday after the biotech company and partner Merck…
-
STOCK MARKET
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
by userby user[ad_1] Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion,…
-
STOCK MARKET
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
by userby user[ad_1] Pfizer Inc.’s stock tumbled 4% premarket Friday, after the company said it would not…
-
STOCK MARKET
Bayer shares plunge by more than 20% after trial of potential blockbuster drug halted
by userby user[ad_1] Bayer lost a fifth of its market value at one point Monday, after the…
-
STOCK MARKET
Verve Therapeutics stock falls 40% as analysts question safety of cholesterol-cutting gene-editing treatment
by userby user[ad_1] Verve Therapeutics Inc. shares VERV, -44.39% fell 40% premarket on Monday after the biotech…
-
STOCK MARKET
Novo Nordisk’s Wegovy cuts risk of heart attack and stroke by 20% among people without diabetes, study finds
by userby user[ad_1] Novo Nordisk’s popular weight-loss drug Wegovy significantly cut the risk of heart attack, stroke or…
-
[ad_1] In the era where innovation is the linchpin of staying competitive, the video game…
-
STOCK MARKET
Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait
by userby user[ad_1] Amgen Inc.’s stock fell 3.3% Tuesday to put it on track for its biggest…
-
[ad_1] Renowned as the “startup nation”, Israel’s vibrant technological ecosystem stands as a testament to…